ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,529,880 | -35.8% | 228,000 | -15.6% | 4.32% | -27.9% |
| Q1 2023 | $2,384,100 | +7.7% | 270,000 | -6.8% | 6.00% | -7.1% |
| Q4 2022 | $2,213,507 | +7.3% | 289,726 | 0.0% | 6.45% | +89.3% |
| Q3 2022 | $2,063,000 | +34.4% | 289,726 | +52.7% | 3.41% | -17.9% |
| Q2 2022 | $1,535,000 | -26.0% | 189,726 | +211.0% | 4.15% | +332.5% |
| Q3 2021 | $2,073,000 | -79.4% | 61,000 | -75.2% | 0.96% | -56.9% |
| Q2 2021 | $10,060,000 | -20.9% | 246,200 | -22.1% | 2.23% | -28.0% |
| Q1 2021 | $12,722,000 | – | 316,000 | – | 3.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |